Release Date: 29/07/10 16:04 Summary: June 2010 Quarterly Report Price Sensitive: Yes Download Document 324.17KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%